Laboratorios Richmond S.A.C.I.F. (BCBA:RICH)

Argentina flag Argentina · Delayed Price · Currency is ARS
1,620.00
+10.00 (0.62%)
Jun 12, 2026, 4:42 PM BRT
Market Cap128.80B +7.0%
Revenue (ttm)119.64B -9.9%
Net Income16.73B -39.2%
EPS207.24 -39.2%
Shares Out 80.75M
PE Ratio8.02
Forward PEn/a
Dividend26.89 (1.69%)
Ex-Dividend DateJun 12, 2026
Volume2,362
Open1,625.00
Previous Close1,610.00
Day's Range1,590.00 - 1,625.00
52-Week Range945.00 - 2,300.00
Beta-0.59
Analystsn/a
Price Targetn/a
Earnings DateAug 10, 2026

About BCBA:RICH

Laboratorios Richmond S.A.C.I.F., together with its subsidiaries, develops, manufactures, and sells pharmaceutical products in Latin America, Africa, Asia, and the Middle East. It offers antiretroviral drugs for the treatment of human immunodeficiency virus; oncology and oncohematology drugs; cardiometabolism drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs, such as analgesics, antipsychotics, antidepressants, anti-dementia, antiepileptics, and hypnot... [Read more]

Sector Healthcare
Founded 1959
Employees 620
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol RICH
Full Company Profile

Financial Performance

In 2025, BCBA:RICH's revenue was 126.73 billion, an increase of 4.95% compared to the previous year's 120.75 billion. Earnings were 3.09 billion, a decrease of -90.16%.

Financial Statements